Cite
HARVARD Citation
Yin, J. et al. (2021). Tetrandrine may treat membranous glomerulopathy via P13K/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model. Bioengineered. 12 (1), pp. 6499-6515. [Online].